Importantly, this CARS2/CPERS-dependent inhibitory mechanism of CD4+ T cell proliferation seems to be operative also in humans, as evidenced by the findings that IBD patients had rapidly proliferating CD4+ T cells with lower CARS2/CPERS expression and that CD4+ T cell proliferation was inhibited by GSSSG supplementation in vitro. Here, CD4 is linked to inflammatory bowel disease.